These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25663456)

  • 1. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
    He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
    Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice.
    Tang X; Zhu Y; Han L; Kim AL; Kopelovich L; Bickers DR; Athar M
    J Clin Invest; 2007 Dec; 117(12):3753-64. PubMed ID: 18060030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.
    Xu J; Timares L; Heilpern C; Weng Z; Li C; Xu H; Pressey JG; Elmets CA; Kopelovich L; Athar M
    Cancer Res; 2010 Aug; 70(16):6566-76. PubMed ID: 20682800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.
    Madka V; Zhang Y; Li Q; Mohammed A; Sindhwani P; Lightfoot S; Wu XR; Kopelovich L; Rao CV
    Neoplasia; 2013 Aug; 15(8):966-74. PubMed ID: 23908596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorogenic acid induces apoptosis and cell-cycle arrest in colorectal cancer cells.
    Ranjbary AG; Bagherzadeh A; Sabbaghi SS; Faghihi A; Karimi DN; Naji S; Kardani M
    Mol Biol Rep; 2023 Dec; 50(12):9845-9857. PubMed ID: 37847443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy.
    Michaeli O; Luz I; Vatarescu M; Manko T; Weizman N; Korotinsky Y; Tsitrina A; Braiman A; Arazi L; Cooks T
    Cell Death Dis; 2024 Jun; 15(6):426. PubMed ID: 38890278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway.
    Zhao Y; Ma R; Wang C; Hu R; Wu W; Sun X; Chen B; Zhang W; Chen Y; Zhou J; Yuan P
    Mol Cell Probes; 2023 Oct; 71():101919. PubMed ID: 37468079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Therapy Using a
    An BC; Ryu Y; Yoon YS; Choi O; Park HJ; Kim TY; Kim SI; Kim BK; Chung MJ
    Mol Cells; 2019 Nov; 42(11):755-762. PubMed ID: 31707776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 loss creates therapeutic vulnerability in colorectal cancer.
    Liu Y; Zhang X; Han C; Wan G; Huang X; Ivan C; Jiang D; Rodriguez-Aguayo C; Lopez-Berestein G; Rao PH; Maru DM; Pahl A; He X; Sood AK; Ellis LM; Anderl J; Lu X
    Nature; 2015 Apr; 520(7549):697-701. PubMed ID: 25901683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription.
    An N; Peng H; Hou M; Su D; Wang L; Shen X; Zhang M
    Oncol Res; 2023; 31(3):307-316. PubMed ID: 37305392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of a modified p53 C-terminal peptide by using a tumor-targeting sequence on cellular apoptosis and tumor treatment.
    Guo X; Zhang Y; Li Q; Shi F; HuangFu Y; Li J; Lao X
    Apoptosis; 2024 Jun; 29(5-6):865-881. PubMed ID: 38145442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle encapsulation of non-genotoxic p53 activator Inauhzin-C for improved therapeutic efficacy.
    Bhattarai N; Wang J; Nguyen D; Yang X; Helmers L; Paruch J; Li L; Zhang Y; Meng K; Wang A; Jayawickramarajah J; Wang B; Zeng S; Lu H
    Theranostics; 2021; 11(14):7005-7017. PubMed ID: 34093867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
    Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
    Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.
    Malkomes P; Lunger I; Oppermann E; Lorenz J; Faqar-Uz-Zaman SF; Han J; Bothur S; Ziegler P; Bankov K; Wild P; Bechstein WO; Rieger MA
    Cancer Gene Ther; 2023 Oct; 30(10):1346-1354. PubMed ID: 37443286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Effect of Sargassum oligocystom Hydroalcoholic Extract Against SW742, HT-29, WiDr, and CT-26 Colorectal Cancer Cell Lines and Expression of P53 and APC Genes.
    Al-Aadily IRJ; Bajilan SI; Al-Koofee DAF; Al-Marzoqi AH
    J Gastrointest Cancer; 2023 Mar; 54(1):62-66. PubMed ID: 35000070
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wu R; Zhao J; Wei P; Tang M; Ma Z; Zhao Y; Du L; Wan L
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.
    Ji L; Xu J; Liu J; Amjad A; Zhang K; Liu Q; Zhou L; Xiao J; Li X
    J Biol Chem; 2015 May; 290(18):11729-40. PubMed ID: 25767119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
    Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X
    Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophore.
    Blanden AR; Yu X; Wolfe AJ; Gilleran JA; Augeri DJ; O'Dell RS; Olson EC; Kimball SD; Emge TJ; Movileanu L; Carpizo DR; Loh SN
    Mol Pharmacol; 2015 May; 87(5):825-31. PubMed ID: 25710967
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.